Publication Boosts Liraglutide for Obesity, but Cost an Issue Publication Boosts Liraglutide for Obesity, but Cost an Issue
One-year data, now published, demonstrate significant weight loss and improved metabolic parameters with liraglutide in overweight and obese adults without diabetes at baseline. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Obesity | Victoza | Weight Loss